rs62415828

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.4352T>C​(p.Ile1451Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,550,906 control chromosomes in the GnomAD database, including 13,837 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 925 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12912 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.127

Publications

14 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013107657).
BP6
Variant 6-64591515-A-G is Benign according to our data. Variant chr6-64591515-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.4352T>C p.Ile1451Thr missense_variant Exon 26 of 43 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.4352T>C p.Ile1451Thr missense_variant Exon 26 of 44 NP_001278938.1 Q5T1H1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.4352T>C p.Ile1451Thr missense_variant Exon 26 of 43 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.4352T>C p.Ile1451Thr missense_variant Exon 26 of 44 1 ENSP00000359655.3 Q5T1H1-3

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15364
AN:
151956
Hom.:
928
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0369
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.125
Gnomad ASJ
AF:
0.0722
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0741
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.0989
GnomAD2 exomes
AF:
0.119
AC:
18198
AN:
153184
AF XY:
0.119
show subpopulations
Gnomad AFR exome
AF:
0.0311
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.0821
Gnomad EAS exome
AF:
0.175
Gnomad FIN exome
AF:
0.0819
Gnomad NFE exome
AF:
0.133
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.132
AC:
185231
AN:
1398832
Hom.:
12912
Cov.:
35
AF XY:
0.132
AC XY:
91110
AN XY:
689964
show subpopulations
African (AFR)
AF:
0.0306
AC:
966
AN:
31582
American (AMR)
AF:
0.135
AC:
4828
AN:
35702
Ashkenazi Jewish (ASJ)
AF:
0.0797
AC:
2006
AN:
25162
East Asian (EAS)
AF:
0.145
AC:
5171
AN:
35734
South Asian (SAS)
AF:
0.105
AC:
8289
AN:
79230
European-Finnish (FIN)
AF:
0.0808
AC:
3978
AN:
49260
Middle Eastern (MID)
AF:
0.0574
AC:
327
AN:
5696
European-Non Finnish (NFE)
AF:
0.141
AC:
152453
AN:
1078476
Other (OTH)
AF:
0.124
AC:
7213
AN:
57990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
9595
19190
28784
38379
47974
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5584
11168
16752
22336
27920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.101
AC:
15362
AN:
152074
Hom.:
925
Cov.:
32
AF XY:
0.0994
AC XY:
7395
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0368
AC:
1530
AN:
41522
American (AMR)
AF:
0.125
AC:
1901
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0722
AC:
250
AN:
3464
East Asian (EAS)
AF:
0.165
AC:
847
AN:
5132
South Asian (SAS)
AF:
0.112
AC:
542
AN:
4820
European-Finnish (FIN)
AF:
0.0741
AC:
786
AN:
10614
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9184
AN:
67948
Other (OTH)
AF:
0.0979
AC:
206
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
697
1394
2090
2787
3484
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
2587
Bravo
AF:
0.105
TwinsUK
AF:
0.135
AC:
501
ALSPAC
AF:
0.127
AC:
491
ESP6500AA
AF:
0.0354
AC:
49
ESP6500EA
AF:
0.140
AC:
447
ExAC
AF:
0.0978
AC:
2111
Asia WGS
AF:
0.122
AC:
423
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Sep 19, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 11, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa 25 Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
12
DANN
Benign
0.15
DEOGEN2
Benign
0.034
.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.98
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.22
T;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.55
N;N
PhyloP100
0.13
PrimateAI
Benign
0.32
T
PROVEAN
Benign
1.7
N;N
REVEL
Benign
0.097
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.029
MPC
0.0095
ClinPred
0.0019
T
GERP RS
0.46
Varity_R
0.046
gMVP
0.083
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62415828; hg19: chr6-65301408; COSMIC: COSV107369957; COSMIC: COSV107369957; API